Overview Fundamentals API Earnings EOD API Sample Code Pricing

Sagimet Biosciences Inc. (SGMT NASDAQ) stock market data APIs

$3.37 0.15(4.7%) as of July 18, 2024
Price chart is built with Anychart

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company's lead drug candidate is Denifanstat, a once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other oncology programs. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Sagimet Biosciences Inc. Financial Data Overview

108 M
30 393 K
2 000 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SGMT',
Type: 'Common Stock',
Name: 'Sagimet Biosciences Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG0020584Y9',
CIK: '1400118',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2023-07-14',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Sagimet Biosciences Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 000 K
  • EBITDA 0
  • Earnings Per Share -0.87
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Sagimet Biosciences Inc. Earnings via APIs

  • Latest Release 2024-05-15
  • EPS/Forecast -0.4

Get Sagimet Biosciences Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?